Locus-coeruleus Function in Normal Elderly and AD Risk

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 6, 2020

Primary Completion Date

March 26, 2024

Study Completion Date

March 26, 2024

Conditions
Alzheimer Disease
Interventions
PROCEDURE

Nocturnal polysomnography (NPSG)

Nocturnal polysomnography (NPSG) to measure REM sleep and sleep spindles characteristics.

PROCEDURE

Lumbar Puncture (LP)

Lumbar puncture (LP) to measure CSF P-Tau, T-Tau and Aβ42/40 ratio.

OTHER

PET-MR measurement with a norepinephrine transporter (NET)-selective radiotracer (S,S)-[11C]Omethylreboxetine ([11C]MRB)

PET-MR measurement with a norepinephrine transporter (NET)-selective radiotracer (S,S)-\[11C\]O-methylreboxetine (\[11C\]MRB) to measure NET availability.

BEHAVIORAL

Psychomotor Vigilance Task (PVT)

Psychomotor vigilance task (PVT) and the OddBall to measure test taskattention performance.

Trial Locations (2)

10016

NYU Grossman School of Medicine, New York

10029

Icahn School of Medicine Mount Sinai, New York

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

NYU Langone Health

OTHER

NCT04403165 - Locus-coeruleus Function in Normal Elderly and AD Risk | Biotech Hunter | Biotech Hunter